CMB 1.43% 35.5¢ cambium bio limited

Ann: Patent granted for allogeneic stem cell technology platform, page-17

  1. 163 Posts.
    lightbulb Created with Sketch. 3
    Bubby-no dilemma. Edison spruiked 2 new distribution/marketing partnership agreements by year end to bring mkt cap to $100 mil. One so far & SP down 30%. Next within 6 wks worth +$80 mil valuation....can't wait Good luck influencing mgmt. AGM was opportunity & exec decisions supported by SH vote, incl cap raise. Prepare your fury & sell orders.

    Agree znew. Pipeline regardless, some of the worst mgmt performance indicators & comms in sector.
    With SP tanked -55% (now 65%) & impressive destruction of SH value & mtk cap...this co mgmt then awarded CEO and CSO (ex-CEO) very large cash + options performance bonuses(!?) Taking $ off the table with short cash runway, investors hammered & need to tap mkt w/ another cap raise. Appalling & says much about "improving investor confidence/sentiment & giving something back to investors".

    Best SH option now IP/pipeline buyout by well capitalised competent mgmt. If co employees assigned invention rights & co owns IP....
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.005(1.43%)
Mkt cap ! $4.235M
Open High Low Value Volume
35.0¢ 35.5¢ 35.0¢ $233 662

Buyers (Bids)

No. Vol. Price($)
1 128 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 1910 1
View Market Depth
Last trade - 15.32pm 19/08/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.